Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Hepatitis C in kwetsbare groepen
okt 2020 | Hepatitis, Hepatologie, Virale infecties